Stocks Health care INCR

NASDAQ · Health care

Intercure Ltd. (INCR)

Intercure Ltd. reported revenue of ₪238.8M in fiscal 2024, down 32.8% from a year earlier. It posted a net loss of ₪67.8M. In fiscal 2024 capital spending exceeded operating cash flow by ₪71.3M. At December 31, 2024 it held ₪78.3M in cash against ₪183M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 30, 2026.

Watch INCR in 60 seconds

Follow INCR

Free, no password. An email when INCR files with the SEC.

Key facts about Intercure Ltd.

Net worth

Intercure Ltd. has a market value (market cap) of $215M at the latest share price, and shareholders' equity of ₪397M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2024 revenue was ₪238.8M (-32.8% year on year), with a net loss of ₪67.8M.

Cash flow

In fiscal 2024 operations used ₪66.9M of cash.

Latest report

The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on April 30, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Intercure Ltd. does

Intercure Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker INCR.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in ILS.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where INCR ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Intercure Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 8, 2026
   Foreign issuer update 6-K
2. August 27, 2026
   Foreign issuer update (amended) 6-K/A
3. August 26, 2026
   Foreign issuer update 6-K
4. August 24, 2026
   Foreign issuer update 6-K
5. August 11, 2026
   Foreign issuer update 6-K
6. August 4, 2026
   Foreign issuer update 6-K
7. July 27, 2026
   Foreign issuer update (amended) 6-K/A
8. July 22, 2026
   Foreign issuer update 6-K
9. June 22, 2026
   Foreign issuer update 6-K
10. June 15, 2026
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 7, the latest on August 24, 2026. Insider transactions on SEC

Insider trades

What the people running Intercure Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns INCR

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about INCR

What does Intercure Ltd. do?

Intercure Ltd. is a company in the Health care sector, listed on NASDAQ as INCR. Its shares trade on NASDAQ under the ticker INCR.

What is Intercure Ltd.'s net worth?

Intercure Ltd. has a market value (market cap) of $215M at the latest share price, and shareholders' equity of ₪397M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Intercure Ltd. profitable?

No. In fiscal 2024 it reported a net loss of ₪67.8M on revenue of ₪238.8M.

How much revenue does Intercure Ltd. make?

In fiscal 2024 Intercure Ltd. reported revenue of ₪238.8M. That is 32.8% less than a year earlier.

When did Intercure Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 8, 2026.

Similar companies

Compare INCR with

Compare INCR with any company

Follow INCR

Get an email when Intercure Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow INCR

Free, no password. An email when INCR files with the SEC.

Where the numbers come from

Financial figures are the values Intercure Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.